All In Biotech

Drug Trial Radar · NCT02128763

Dry Eye Assessment and Management Study

Last checked: Nov 20, 2026Latest source record: Jul 19, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 535 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

535

Actual

Start

Nov 2014

Primary completion

Sep 5, 2017

Study completion Jan 31, 2020

Sponsor

Lead sponsor
University of PennsylvaniaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Eye Institute (NEI)
First posted
May 1, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of the DREAM study is to evaluate the effectiveness and safety of supplementation with omega-3 fatty acids in relieving the symptoms of moderate to severe dry eye disease.

Conditions

  • Dry Eye

Interventions

  • Omega-3 supplementsDrug

    2000 mg EPA and 1000 mg DHA per day

  • PlaceboDrug

    Olive oil gelcaps manufactured to mimic Omega-3 gelcaps

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean of Change From Baseline in Ocular Surface Disease Index (OSDI) Score at 6 and 12 MonthsTime frame: 12 months

Locations

27 sites in 1 country. Site status is shown where the registry gives one.

  • Stephen Cohen, OD PC

    Scottsdale, Arizona

  • Mayo Clinic Arizona

    Scottsdale, Arizona

  • Milton M. Hom, OD, FAAO

    Azusa, California

  • University of California, Berkeley

    Berkeley, California

  • Pendleton Eye Center

    Oceanside, California

  • Wolstan and Goldberg Eye Associates

    Torrance, California

  • Shettle Eye Research

    Largo, Florida

  • Eye Care Centers Management, Inc.

    Morrow, Georgia

  • University of Illinois Hospital & Health Sciences

    Chicago, Illinois

  • Price Vision Group

    Indianapolis, Indiana

  • KU Eye Center

    Prairie Village, Kansas

  • Tufts Medical Center

    Boston, Massachusetts

  • Massachusetts Eye and Ear Infirmary

    Boston, Massachusetts

  • Clinical Eye Research of Boston

    Winchester, Massachusetts

  • University of Michigan Kellogg Eye Center

    Ann Arbor, Michigan

  • Minnesota Eye Consultants, P.A.

    Bloomington, Minnesota

  • Mulqueeny Eye Centers

    Creve Coeur, Missouri

  • Tauber Eye Center

    Kansas City, Missouri

  • Silverstein Eye Centers

    Kansas City, Missouri

  • Icahn School of Medicine at Mount Sinai

    New York, New York

  • Universtity of Rochester-Flaum Eye Institute

    Rochester, New York

  • Oculus Research at Garner at Eyecarecenter

    Raleigh, North Carolina

  • Case Western Reserve University

    Cleveland, Ohio

  • Northeast Ohio Eye Surgeons

    Kent, Ohio

  • Scheie Eye Institute, University of Pennsylvania

    Philadelphia, Pennsylvania

  • Southern College of Optometry

    Memphis, Tennessee

  • The Eye Centers of Racine and Kenosha

    Racine, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.